| Hans-Günter Meyer-Thompson | Wechselwirkungen mit Substitutionsmitteln
Part 2: Drug Interactions Involving Cannabis Products in Persons Aged 18 and Over: A Summary of Published Case Reports and Analysis of the FDA Adverse Event Reporting System.
Part 2: Drug Interactions Involving Cannabis Products in Persons Aged 18 and Over: A Summary of Published Case Reports and Analysis of the FDA Adverse Event Reporting System.
Chapin MR, Kane-Gill SL, Li X, Abanyie K, Taneja SB, Egbert S, Paine MF, Boyce RD.
Pharmacol Res Perspect. 2025 Feb;13(1):e70047. doi: 10.1002/prp2.70047. PMID: 39719832; PMCID: PMC11668913.